# Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

> **NCT07366710** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 36 (estimated)

## Conditions studied

- Glucose Metabolism
- NAFLD (Nonalcoholic Fatty Liver Disease)

## Interventions

- **DRUG:** 18F-FDG (oral)
- **DRUG:** 18F-FDG (intravenous)
- **DRUG:** 18F-FET (oral)
- **DRUG:** 18F-FET (intravenous)
- **DRUG:** Glucagon
- **DRUG:** Somatostatin
- **DRUG:** Sodium chloride (placebo)
- **OTHER:** Oral Glucose Tolerance Test

## Key facts

- **NCT ID:** NCT07366710
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-05
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07366710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07366710, "Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07366710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*